Xolair 150 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB25FZX98
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $9,284
Award facts
- Contract value 100% obligated
- $9,284.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $9,284.40 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on September 15, 2025, for the supply of Xolair 150 mg/ml syringes. The award carries an ultimate completion date of October 6, 2025, and does not utilize a set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the delivery at its location in Park Ridge, IL 60068.
This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $499.9 billion vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products for military health facilities worldwide. Xolair (omalizumab) is a monoclonal antibody used primarily in the treatment of moderate to severe allergic asthma and chronic idiopathic urticaria, making this delivery order part of the broader pharmaceutical supply chain supporting Department of Defense healthcare operations. The contractor's established portfolio with the Defense Logistics Agency demonstrates its capability in delivering specialized pharmaceutical products to federal healthcare systems across the military health network.
Quick answers
Who was awarded contract SPE2DB25FZX98?
SPE2DB25FZX98 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 15, 2025.
How much is contract SPE2DB25FZX98 worth?
The government has obligated $9,284 on SPE2DB25FZX98.
Is contract SPE2DB25FZX98 an order under another contract?
Yes. SPE2DB25FZX98 is a delivery order under SPE2DB20D9135, an indefinite delivery contract.
Was contract SPE2DB25FZX98 competed?
The extent of competition for SPE2DB25FZX98 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award